Show simple item record

Endometrial cancer risk in postmenopausal breast cancer patients treated with tamoxifen or aromatase inhibitors

dc.contributor.authorSestak, Ien_US
dc.contributor.authorCuzick, Jen_US
dc.date.accessioned2020-08-13T14:30:25Z
dc.date.available2016-07-19en_US
dc.date.issued2016en_US
dc.identifier.issn1744-6651en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/66265
dc.format.extent425 - 432en_US
dc.relation.ispartofEXPERT REVIEW OF ENDOCRINOLOGY & METABOLISMen_US
dc.subjectEndometrial canceren_US
dc.subjectbreast canceren_US
dc.subjectendocrine therapyen_US
dc.subjecttamoxifenen_US
dc.subjectaromatase inhibitoren_US
dc.titleEndometrial cancer risk in postmenopausal breast cancer patients treated with tamoxifen or aromatase inhibitorsen_US
dc.typeArticle
dc.identifier.doi10.1080/17446651.2016.1216101en_US
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000386694400009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue5en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume11en_US


Files in this item

Thumbnail
Name:
Šestak Endometrial cancer risk ...
Size:
152.3Kb
Format:
application/
Description:
Accepted version
View/Open

This item appears in the following Collection(s)

Show simple item record